Direct Answer
Bio-Techne reports revenue across 2 business segments in its fiscal 2025 Form 10-K. Protein Sciences is the largest, with $870 million of revenue (71% of the total), followed by Diagnostics and Spatial Biology at $346 million (28%). 56% of revenue came from the United States.
How Does Bio-Techne Make Money?
Protein Sciences supplies 71% of revenue, so Bio-Techne's results move mostly with that one business; the others matter more for diversification than for the headline number. Between fiscal 2024 and 2025, Diagnostics and Spatial Biology grew fastest (+6.1%) and Protein Sciences slowest (+4.7%), so the revenue mix tilts toward Diagnostics and Spatial Biology while that gap lasts.
| Segment | FY2025 revenue | FY2024 revenue | Share of revenue | Change |
|---|---|---|---|---|
| Protein Sciences | $870 million | $831 million | 71.4% | 4.7% |
| Diagnostics and Spatial Biology | $346 million | $326 million | 28.4% | 6.1% |
Which Bio-Techne Segments Earn the Most?
| Segment | FY2025 segment operating income | Segment margin |
|---|---|---|
| Protein Sciences | $370 million | 42.6% |
| Diagnostics and Spatial Biology | $21 million | 6.2% |
Segment operating income is the profit measure Bio-Techne reports to its chief operating decision maker for each segment. It usually leaves out corporate costs that are not allocated to a segment, so the segments usually add up to more than consolidated operating income, and margins are comparable within Bio-Techne more safely than against another company.
What Does Bio-Techne Sell?
Bio-Techne also breaks revenue down by product and service line, which shows what customers pay for rather than how management organizes the business.
| Product or service | FY2025 revenue | FY2024 revenue | Share of revenue | Change |
|---|---|---|---|---|
| Consumables | $972 million | $928 million | 79.7% | 4.8% |
| Instruments | $112 million | $108 million | 9.2% | 3.5% |
| Service | $112 million | $99 million | 9.1% | 12.4% |
| Royalty | $24 million | $23 million | 1.9% | 1.5% |
Where Does Bio-Techne's Revenue Come From?
Regions follow the definitions in the filing; most companies assign revenue by customer location.
| Region | FY2025 revenue | FY2024 revenue | Share of revenue | Change |
|---|---|---|---|---|
| United States | $683 million | $658 million | 56.0% | 3.9% |
| EMEA Excluding UK | $266 million | $241 million | 21.8% | 10.3% |
| China | $100 million | $99 million | 8.2% | 1.0% |
| APAC Excluding Greater China | $77 million | $74 million | 6.3% | 4.5% |
| United Kingdom | $55 million | $50 million | 4.5% | 9.6% |
| Rest of World | $38 million | $36 million | 3.1% | 2.9% |
What the Segment Figures Do Not Show
The rows above add up to 100% of Bio-Techne's reported revenue for fiscal 2025; the difference is intersegment eliminations, corporate revenue or items the company reports outside its segments. Segment definitions are management's choice and change when a company reorganizes, in which case it restates prior years in the next filing, so a multi-year comparison should use the figures from a single filing. Revenue shows where sales come from, not where profit or cash is earned: a small segment can carry most of the margin.
Where These Numbers Come From
Every figure on this page is a value Bio-Techne reported in the segment note and revenue disclosures of its Form 10-K filed August 22, 2025 (accession 0001558370-25-011716), read from the SEC's Financial Statement Data Sets. The prior-year column is the comparative figure from that same filing, so it reflects any restatement for a change in segments. Category names are the company's own XBRL labels, lightly reformatted for reading.
Rows that only total other rows (for example a "Products" line beside the individual products) are left out so nothing is counted twice. This page is educational and describes reported history for fiscal 2025; it is not a forecast or a recommendation.
Frequently Asked Questions
What are Bio-Techne's business segments?
In its fiscal 2025 Form 10-K, Bio-Techne reports revenue for Protein Sciences and Diagnostics and Spatial Biology.
Which part of Bio-Techne brings in the most revenue?
Protein Sciences, with $870 million of revenue in fiscal 2025, or 71% of the total.
How much of Bio-Techne's revenue comes from outside the United States?
44% in fiscal 2025, by the geographic breakdown Bio-Techne reports in its Form 10-K. Companies assign revenue to regions differently (customer location, shipping address or selling entity), so check the filing's definition before comparing companies.